Showing 2,829 results

Filters Content type: News, Editors' picks, About HIV Topic: PrEP

Pre-exposure prophylaxis involves people who do not have HIV taking antiretroviral drugs when they are at risk of exposure to HIV in order to prevent infection. The drugs are usually taken as pills (oral PrEP).

Pharmaceutical industry

HIV Affects Millions of Women. So Why Isn’t a New PrEP Drug Approved for Their Use?

Editor's pick
Rewire News
3 December 2019
PrEP policies & guidelines

Boris Johnson wants you to ‘fight’ HIV despite not including a single commitment to PrEP in Tory manifesto

Editor's pick
Pink News
2 December 2019
PrEP policies & guidelines

If the NHS was ‘for sale,’ what would it mean for PrEP?

Editor's pick
PinkNews
2 December 2019
PrEP policies & guidelines

General election 2019: Labour and Lib Dems pledge wider access to HIV drug

Editor's pick
BBC News
2 December 2019
PrEP programmes & uptake

South Africa: HIV PrEP is available, but why aren’t people taking it?

Editor's pick
Daily Maverick
2 December 2019
HIV treatment

Top 10 HIV Clinical Developments of 2019

Editor's pick
TheBodyPro
27 November 2019
People & personal stories

8 Months Ago, I Was Diagnosed with HIV While on PrEP

Editor's pick
TheBody
26 November 2019
PrEP programmes & uptake

People Seeking PrEP Face Numerous Nonfinancial Roadblocks

Editor's pick
POZ
25 November 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
PrEP policies & guidelines

Barring cisgender women from the Descovy trials was a bad call

Editor's pick
STAT
25 November 2019
Treatment interruptions

Second case of unintended HIV transmission during HIV cure study prompts questions about PrEP provision

News
22 November 2019
PrEP programmes & uptake

Intermittent and lower-risk PrEP users may not be testing for HIV and STIs, German study finds

News
22 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
Mental & emotional health & wellbeing

PrEP users have less HIV anxiety

News
21 November 2019
PrEP science

Serosorting between gay men may be in decline as ‘PrEP sorting’ rises, Canadian study finds

News
20 November 2019
Hepatitis C transmission & prevention

Hepatitis C incidence is low among Canadian men on PrEP

News
15 November 2019
PrEP science

How do we deal with apparent cases of PrEP failure?

News
15 November 2019
PrEP science

96-week results of DISCOVER PrEP trial presented at European AIDS Conference

News
14 November 2019
People & personal stories

The Berlin Patient, the First Person Ever Cured of HIV, on Taking PrEP: "I Want a Full Sexual Life"

Editor's pick
TheBodyPro
12 November 2019
HIV prevention policy

Did The CDC's Jonathan Mermin Prevent PrEP Access to the Public?

Editor's pick
HIV Plus
12 November 2019
Pharmaceutical industry

Untangling the Trump administration's lawsuit over an HIV prevention drug

Editor's pick
Science
11 November 2019
PrEP programmes & uptake

French study finds one in six stops PrEP within 12 months, one in three after 30 months

News
11 November 2019
PrEP science

Descovy for PrEP Continues to Be Noninferior to Truvada, According to 96 Week Data

Editor's pick
Monthly Prescribing Reference
8 November 2019
Pharmaceutical industry

U.S. sues drugmaker Gilead over patents on HIV prevention treatment

Editor's pick
San Francisco Chronicle
8 November 2019